Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 4/2015

01.08.2015 | Original Article

Exercise as Treatment for Anxiety: Systematic Review and Analysis

verfasst von: Gregory L. Stonerock, Ph.D., Benson M. Hoffman, Ph.D., Patrick J. Smith, Ph.D., James A. Blumenthal, Ph.D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Exercise has been shown to reduce symptoms of anxiety, but few studies have studied exercise in individuals preselected because of their high anxiety.

Purpose

The objective of this study is to review and critically evaluate studies of exercise training in adults with either high levels of anxiety or an anxiety disorder.

Methods

We conducted a systematic review of randomized clinical trials (RCTs) in which anxious adults were randomized to an exercise or nonexercise control condition. Data were extracted concerning anxiety outcomes and study design. Existing meta-analyses were also reviewed.

Results

Evidence from 12 RCTs suggested benefits of exercise, for select groups, similar to established treatments and greater than placebo. However, most studies had significant methodological limitations, including small sample sizes, concurrent therapies, and inadequate assessment of adherence and fitness levels.

Conclusions

Exercise may be a useful treatment for anxiety, but lack of data from rigorous, methodologically sound RCTs precludes any definitive conclusions about its effectiveness.
Literatur
1.
Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association; 2013.
2.
Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen H-U. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012; 21: 169-184.PubMedCentralPubMed
3.
Haller H, Cramer H, Lauche R, Gass F, Dobos G. The prevalence and burden of subthreshold generalized anxiety disorder: a systematic review. BMC Psychiatry. 2014; 14: 128.PubMedCentralPubMed
4.
Stein MB, Roy-Byrne PP, Craske MG, et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care. 2005; 43: 1164-1170.PubMed
5.
Tolmunen T, Lehto SM, Julkunen J, Hintikka J, Kauhanen J. Trait anxiety and somatic concerns associate with increased mortality risk: a 23-year follow-up in aging men. Ann Epidemiol. 2014; 24: 463-468.PubMed
6.
Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010; 56: 38-46.PubMed
7.
Janszky I, Ahnve S, Lundberg I, Hemmingsson T. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol. 2010; 56: 31-37.PubMed
8.
Roest AM, Martens EJ, Denollet J, de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med. 2010; 72: 563-569.PubMed
9.
Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008; 65: 62-71.PubMed
10.
Frasure-Smith N. In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men. Am J Cardiol. 1991; 67: 121-127.PubMed
11.
Tully PJ, Baker RA, Knight JL. Anxiety and depression as risk factors for mortality after coronary artery bypass surgery. J Psychosom Res. 2008; 64: 285-290.PubMed
12.
Tully P, Baker R, Turnbull D, Winefield H. The role of depression and anxiety symptoms in hospital readmissions after cardiac surgery. J Behav Med. 2008; 31: 281-290.PubMed
13.
Szekely A, Balog P, Benko E, et al. Anxiety predicts mortality and morbidity after coronary artery and valve surgery—a 4-year follow-up study. Psychosom Med. 2007; 69: 625-631.PubMed
14.
Moser DK, McKinley S, Riegel B, et al. Relationship of persistent symptoms of anxiety to morbidity and mortality outcomes in patients with coronary heart disease. Psychosom Med. 2011; 73: 803-809.PubMed
15.
Watkins LL, Koch GG, Sherwood A, et al. Association of anxiety and depression with all‐cause mortality in individuals with coronary heart disease. J Am Heart Assoc. 2013; 2.
16.
Rothenbacher D, Hahmann H, Wusten B, Koenig W, Brenner H. Symptoms of anxiety and depression in patients with stable coronary heart disease: prognostic value and consideration of pathogenetic links. Eur J Cardiovasc Prev Rehabil. 2007; 14: 547-554.PubMed
17.
Strik JJ, Denollet J, Lousberg R, Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol. 2003; 42: 1801-1807.PubMed
18.
Shibeshi WA, Young-Xu Y, Blatt CM. Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol. 2007; 49: 2021-2027.PubMed
19.
Markovitz JH, Matthews KA, Kannel WB, Cobb JL, D’Agostino RB. Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? J Am Med Assoc. 1993; 270: 2439-2443.
20.
Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation. 1994; 90: 2225-2229.PubMed
21.
McCarron P, Gunnell D, Harrison GL, Okasha M, Davey Smith G. Temperament in young adulthood and later mortality: prospective observational study. J Epidemiol Community Health. 2003; 57: 888-892.PubMedCentralPubMed
22.
Bonnet F, Irving K, Terra J-L, et al. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005; 178: 339-344.PubMed
23.
Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the national health and nutrition examination survey I epidemiologic follow-up study. Arch Fam Med. 1997; 6: 43-49.PubMed
24.
Barlow DH. Clinical handbook of psychological disorders: A step-by-step treatment manual. 5th ed. New York, NY: The Guilford Press; 2014.
25.
Barlow DH, Gorman JM, Shear M, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. J Am Med Assoc. 2000; 283: 2529-2536.
26.
Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006; 26: 17-31.PubMed
27.
Kapczinski F, Lima MS, Souza JS, Schmitt R. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev. 2003.
28.
Stahl SM, Gergel I, Li D. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2003; 64: 1322-1327.PubMed
29.
Davidson JRT, Bose A, Korotzer A, Zheng H. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study. Depression Anxiety. 2004; 19: 234-240.PubMed
30.
Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005; 19: 567-596.PubMed
31.
Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry. 2002; 180: 104-109.PubMed
32.
Gunter RW, Whittal ML. Dissemination of cognitive-behavioral treatments for anxiety disorders: overcoming barriers and improving patient access. Clin Psychol Rev. 2010; 30: 194-202.PubMed
33.
Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985; 100: 126-131.PubMedCentralPubMed
34.
Goodwin RD. Association between physical activity and mental disorders among adults in the United States. Prev Med. 2003; 36: 698-703.PubMed
35.
De Moor MHM, Beem AL, Stubbe JH, Boomsma DI, De Geus EJC. Regular exercise, anxiety, depression and personality: a population-based study. Prev Med. 2006; 42: 273-279.PubMed
36.
37.
Esquivel G, Diaz-Galvis J, Schruers K, et al. Acute exercise reduces the effects of a 35% CO2 challenge in patients with panic disorder. J Affect Disord. 2008; 107: 217-220.PubMed
38.
Yeung RR. The acute effects of exercise on mood state. J Psychosom Res. 1996; 40: 123-141.PubMed
39.
Berger BG, Owen DR. Relation of low and moderate intensity exercise with acute mood change in college joggers. Percept Mot Skills. 1998; 87: 611-621.PubMed
40.
King AC, Taylor CB, Haskell WL. Effects of differing intensities and formats of 12 months of exercise training on psychological outcomes in older adults. Health Psychol. 1993; 12: 292-300.PubMed
41.
Tsai J-C, Wang W-H, Chan P, et al. The beneficial effects of Tai Chi Chuan on blood pressure and lipid profile and anxiety status in a randomized controlled trial. J Altern Complement Med. 2003; 9: 747-754.PubMed
42.
Stavrakaki C, Vargo B. The relationship of anxiety and depression: a review of the literature. Br J Psychiatry. 1986; 149: 7-16.PubMed
43.
Zung WW, Magruder-Habib K, Velez R, Alling W. The comorbidity of anxiety and depression in general medical patients: a longitudinal study. J Clin Psychiatry. 1990; 51: 77-80.PubMed
44.
Cooney GM, Dwan K, Greig CA, et al. Exercise for depression. Cochrane Database Syst Rev. 2013; 9: Cd004366.PubMed
45.
Mead GE, Morley W, Campbell P, et al. Exercise for depression. Cochrane Database Syst Rev. 2009:Cd004366.
46.
Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ. 2001; 322: 763.PubMedCentralPubMed
47.
Herring MP, O’Connor PJ, Dishman RK. The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med. 2010; 170: 321-331.PubMed
48.
Conn VS. Anxiety outcomes after physical activity interventions: meta-analysis findings. Nurs Res. 2010; 59.
49.
Wipfli BM, Rethorst CD, Landers DM. The anxiolytic effects of exercise: a meta-analysis of randomized trials and dose-response analysis. J Sport Exerc Psychol. 2008; 30: 392-410.PubMed
50.
Jayakody K, Gunadasa S, Hosker C. Exercise for anxiety disorders: systematic review. Br J Sports Med. 2014; 48: 187-196.PubMed
51.
Focht BC, Koltyn KF. Influence of resistance exercise of different intensities on state anxiety and blood pressure. Med Sci Sports Exerc. 1999; 31: 456-463.PubMed
52.
Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003; 83: 713-721.PubMed
53.
Annesi JJ, Gorjala S. Association of reduction in waist circumference with normalization of mood in obese women initiating exercise supported by the Coach Approach protocol. South Med J. 2010; 103: 517-521.PubMed
54.
Hale BS, Raglin JS. State anxiety responses to acute resistance training and step aerobic exercise across 8 weeks of training. J Sports Med Phys Fitness. 2002; 42: 108-112.PubMed
55.
Smith JA, Greer T, Sheets T, Watson S. Is there more to yoga than exercise? Altern Ther Health Med. 2011; 17: 22-29.PubMed
56.
Mussgay L, Schmidt F, Morad E, Ruddel H. Does aerobic exercise modulate baroreflex sensitivity in patients with anxiety and somatization disorders? Homeost Health Dis. 2003; 42: 277-287.
57.
Oeland A-M, Laessoe U, Olesen AV, Munk-Jorgensen P. Impact of exercise on patients with depression and anxiety. Nordic J Psychiatry. 2010; 64: 210-217.
58.
Wedekind D, Sprute A, Broocks A, et al. Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder. Curr Pharm Des. 2008; 14: 3518-3524.PubMed
59.
Gaul-Alacova P, Boucek J, Stejskal P, et al. Assessment of the influence of exercise on heart rate variability in anxiety patients. Neuroendocrinol Lett. 2005; 26: 713-718.PubMed
60.
Lambert RA, Harvey I, Poland F. A pragmatic, unblinded randomised controlled trial comparing an occupational therapy-led lifestyle approach and routine GP care for panic disorder treatment in primary care. J Affect Disord. 2007; 99: 63-71.PubMed
61.
Kim J-H, Yang H, Schroeppel S. A pilot study examining the effects of Kouk Sun Do on university students with anxiety symptoms. Stress Health. 2013; 29: 99-107.PubMed
62.
Faulkner J, Westrupp N, Rousseau J, Lark S. A randomized controlled trial to assess the effect of self-paced walking on task-specific anxiety in cardiac rehabilitation patients. J Cardiopulm Rehabil Prev. 2013; 33: 292-296.PubMed
63.
Martinsen EW, Hoffart A, Solberg OY. Aerobic and non-aerobic forms of exercise in the treatment of anxiety disorders. Stress Med. 1989; 5: 115-120.
64.
Murphy SM, Edwards RT, Williams N, et al. An evaluation of the effectiveness and cost effectiveness of the National Exercise Referral Scheme in Wales, UK: a randomised controlled trial of a public health policy initiative. J Epidemiol Community Health. 2012; 66: 745-753.PubMedCentralPubMed
65.
Sexton H, Maere A, Dahl NH. Exercise intensity and reduction in neurotic symptoms: a controlled follow-up study. Acta Psychiatr Scand. 1989; 80: 231-235.PubMed
66.
Goldstein-Shirley J, Brown M. Intervention of light, exercise and vitamins for mixed anxiety-depression. Communicating Nursing Research. Palm Springs, CA; 2002.
67.
Bandelow B, Broocks A, Pekrun G, et al. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial. Pharmacopsychiatry. 2000; 33: 174-181.PubMed
68.
Broocks A, Bandelow B, Pekrun G, et al. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatr. 1998; 155: 603-609.PubMed
69.
Broocks A, Meyer T, Opitz M, et al. 5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo. Eur Neuropsychopharmacol. 2003; 13: 153-164.PubMed
70.
Goldin P, Ziv M, Jazaieri H, Gross JJ. Randomized controlled trial of mindfulness-based stress reduction versus aerobic exercise: effects on the self-referential brain network in social anxiety disorder. Front Hum Neurosci. 2012.
71.
Goldin P, Ziv M, Jazaieri H, Hahn K, Gross JJ. MBSR vs aerobic exercise in social anxiety: fMRI of emotion regulation of negative self-beliefs. Soc Cogn Affect Neurosci. 2013; 8: 65-72.PubMedCentralPubMed
72.
Jazaieri H, Goldin PR, Werner K, Ziv M, Gross JJ. A randomized trial of MBSR versus aerobic exercise for social anxiety disorder. J Clin Psychol. 2012; 68: 715-731.PubMedCentralPubMed
73.
Herring MP, Jacob ML, Suveg C, Dishman RK, O’Connor PJ. Feasibility of exercise training for the short-term treatment of generalized anxiety disorder: a randomized controlled trial. Psychother Psychosom. 2012; 81: 21-28.PubMed
74.
Herring MP, Jacob ML, Suveg C, O’Connor PJ. Effects of short-term exercise training on signs and symptoms of generalized anxiety disorder. Ment Health Phys Act. 2011; 4: 71-77.
75.
Merom D, Phongsavan P, Wagner R, et al. Promoting walking as an adjunct intervention to group cognitive behavioral therapy for anxiety disorders—a pilot group randomized trial. J Anxiety Disord. 2008; 22: 959-968.PubMed
76.
Phongsavan P, Merom D, Wagner R, et al. Process evaluation in an intervention designed to promote physical activity among adults with anxiety disorders: evidence of acceptability and adherence. Health Promot J Aust. 2008; 19: 137-143.
77.
Oldridge N, Guyatt G, Jones N, et al. Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. Am J Cardiol. 1991; 67: 1084-1089.PubMed
78.
Oldridge N, Streiner D, Hoffmann R, Guyatt G. Profile of mood states and cardiac rehabilitation after acute myocardial infarction. Med Sci Sports Exerc. 1995; 27: 900-905.PubMed
79.
Carmeli E, Barak S, Morad M, Kodesh E. Physical exercises can reduce anxiety and improve quality of life among adults with intellectual disability. Int Sport Med J. 2009; 10: 77-85.
80.
Kim SH, Schneider SM, Bevans M, et al. PTSD symptom reduction with mindfulness-based stretching and deep breathing exercise: randomized controlled clinical trial of efficacy. J Clin Endocrinol Metab. 2013; 98: 2984-2992.PubMedCentralPubMed
81.
Gutiérrez CV, Luque GT, Medina GMÁ, et al. Influence of exercise on mood in postmenopausal women. J Clin Nurs. 2012; 21: 923-928.
82.
Broman-Fulks JJ, Storey KM. Evaluation of a brief aerobic exercise intervention for high anxiety sensitivity. Anxiety Stress Coping. 2008; 21: 117-128.PubMed
83.
Smits JAJ, Berry AC, Rosenfield D, et al. Reducing anxiety sensitivity with exercise. Depression Anxiety. 2008; 25: 689-699.PubMed
84.
Wedekind D, Broocks A, Weiss N, et al. A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder. World J Biol Psychiatry. 2010; 11: 904-913.PubMed
85.
Hovland A, Nordhus IH, Sjobo T, et al. Comparing physical exercise in groups to group cognitive behaviour therapy for the treatment of panic disorder in a randomized controlled trial. Behav Cogn Psychother. 2013; 41: 408-432.PubMedCentralPubMed
86.
Higgins JPT, Green S eds. Cochrane Handbook for Systematic Reviews of Interventions, 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011. Available at www.​cochrane-handbook.​org.
87.
Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. J Am Med Assoc. 1999; 282: 1054-1060.
88.
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J Am Med Assoc. 1995; 273: 408-412.
89.
Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32: 50-55.PubMed
90.
Beck AT, Steer RA. Manual for the Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation; 1990.
91.
Chambless DL, Caputo GC, Bright P, Gallagher R. Assessment of fear of fear in agoraphobics: the Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. J Consult Clin Psychol. 1984; 52: 1090-1097.PubMed
92.
Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther. 1986; 24: 1-8.PubMed
93.
Taylor S, Cox BJ. An expanded Anxiety Sensitivity Index: evidence for a hierarchic structure in a clinical sample. J Anxiety Disord. 1998; 12: 463-483.PubMed
94.
Guy W ed. ECDEU Assessment Manual for Psychopharmacology-Revised. Rockville, MD: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration; 1976.
95.
Lovibond SH, Lovibond PF. Manual for the Depression Anxiety Stress Scales. Sydney, N.S.W: Psychology Foundation of Australia; 1995.
96.
Fresco DM, Coles ME, Heimberg RG, et al. The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats. Psychol Med. 2001; 31: 1025-1035.PubMed
97.
Chambless DL, Caputo GC, Jasin SE, Gracely EJ, Williams C. The mobility inventory for agoraphobia. Behav Res Ther. 1985; 23: 35-44.PubMed
98.
Bandelow B. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. the Panic and Agoraphobia Scale. Int Clin Psychopharmacol. 1995; 10: 73-81.PubMed
99.
Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther. 1996; 34: 669-673.PubMed
100.
Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM: The PTSD Checklist (PCL). Reliability, validity, and diagnostic utility. Annual Convention of the International Society for Traumatic Stress Studies. San Antonio; 1993.
101.
McNair DM, Lorr M, Droppleman L. POMS: Profile of Mood States. North Tonawanda, NY: Multi-Health Systems Inc; 1992.
102.
Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990; 28: 487-495.PubMed
103.
Rodebaugh TL, Woods CM, Heimberg RG. The reverse of social anxiety is not always the opposite: the reverse-scored items of the Social Interaction Anxiety Scale do not belong. Behav Ther. 2007; 38: 192-206.PubMed
104.
Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press; 1983.
105.
Bartley CA, Hay M, Bloch MH. Meta-analysis: aerobic exercise for the treatment of anxiety disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013; 45: 34-39.
106.
Petruzzello SJ, Landers DM, Hatfield BD, Kubitz KA, Salazar W. A meta-analysis on the anxiety-reducing effects of acute and chronic exercise: outcomes and mechanisms. Sports Med. 1991; 11: 143-182.PubMed
107.
Santor DA, Zuroff DC, Ramsay JO, Cervantes P, Palacios J. Examining scale discriminability in the BDI and CES-D as a function of depressive severity. Psychol Assess. 1995; 7: 131-139.
108.
Slade T, Andrews G. Latent structure of depression in a community sample: a taxometric analysis. Psychol Med. 2005; 35: 489-497.PubMed
109.
Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005; 28: 1-8.PubMed
110.
Bartholomew J, Linder D. State anxiety following resistance exercise: the role of gender and exercise intensity. J Behav Med. 1998; 21: 205-219.PubMed
111.
Broman-Fulks JJ, Berman ME, Rabian BA, Webster MJ. Effects of aerobic exercise on anxiety sensitivity. Behav Res Ther. 2004; 42: 125-136.PubMed
112.
Masters KS, Spielmans GI, LaCaille RA, et al. Effects of home exercise on immediate and delayed affect and mood among rural individuals at risk for type 2 diabetes. J Soc Behav Health Sci. 2011; 5: 1-16.
113.
114.
Arch JJ, Craske MG. Acceptance and commitment therapy and cognitive behavioral therapy for anxiety disorders: different treatments, similar mechanisms? Clin Psychol Sci Pract. 2008; 15: 263-279.
115.
Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull. 1979; 86: 638-641.
116.
Easterbrook PJ, Gopalan R, Berlin JA, Matthews DR. Publication bias in clinical research. Lancet. 1991; 337: 867-872.PubMed
Metadaten
Titel
Exercise as Treatment for Anxiety: Systematic Review and Analysis
verfasst von
Gregory L. Stonerock, Ph.D.
Benson M. Hoffman, Ph.D.
Patrick J. Smith, Ph.D.
James A. Blumenthal, Ph.D.
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Annals of Behavioral Medicine / Ausgabe 4/2015
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-014-9685-9

Weitere Artikel der Ausgabe 4/2015

Annals of Behavioral Medicine 4/2015 Zur Ausgabe

Original Article

Do Young Adults Perceive That Cigarette Graphic Warnings Provide New Knowledge About the Harms of Smoking?

Original Article

Educational Status, Anger, and Inflammation in the MIDUS National Sample: Does Race Matter?

Original Article

Determinants of Coach Communication About Concussion Safety in US Collegiate Sport

Original Article

Real-Time Associations Between Engaging in Leisure and Daily Health and Well-Being

Original Article

Using an Extended Theory of Planned Behavior to Predict a Change in the Type of Blood Product Donated

Original Article

Caregiving Motivation Predicts Long-Term Spirituality and Quality of Life of the Caregivers

Neu in den Fachgebieten Neurologie und Psychiatrie

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus
Professorin Dr. Claudia Trenkwalder, Neurologin

23.04.2024 | Depression antepartal oder postpartal | Nachrichten

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

19.04.2024 | AAN-Jahrestagung 2024 | Nachrichten

Hustenstiller lindert Agitation bei Alzheimer